Legal status · United Kingdom
Is BGE-102 legal in the United Kingdom?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. BGE-102 is not approved for any medical use in the United Kingdom. Its legal category is "Investigational, not licensed". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.
- People given it
- 0
- Found nothing
- 0
Legal category
Investigational, not licensed
MHRA licensing and unlicensed medicine status, from the BGE-102 profile.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
BGE-102 in the United Kingdom at a glance
| Legal category | Investigational, not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA; investigational (still being tested in trials) |
| Studies in people | 2 of 2 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the BGE-102 profile. We checked them against Medicines and Healthcare products Regulatory Agency (MHRA) listings on the reviewed date.
What this means
- 01
BGE-102 is being tested in registered clinical trials (official studies in people). MHRA has not approved it for sale in the United Kingdom.
- 02
The only legal ways for a person to get it are to join a trial, or to use an official early-access program where one exists. There is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial supplies. That label does not make them legal to use in people.
What BGE-102 is
BioAge's daily pill that blocks NLRP3, a trigger of long-term inflammation. In an early study, a blood marker of inflammation, hsCRP, fell by a median 86 percent in two weeks.
NLRP3 is a switch inside cells that drives much of the low-level inflammation that builds up with age. In an early study reported in April 2026, adults with obesity and raised inflammation took 120 mg of BGE-102 a day.
How it works: It is a small molecule that blocks the NLRP3 switch. That stops the release of IL-1 beta, a strong inflammation signal.
Approval history: Investigational; in early to mid-stage studies
How MHRA treats this kind of product
Licenses medicines for sale in the UK. A compound without a licence to be sold (a marketing authorisation) is an unlicensed medicine. The law only lets it reach people through a prescriber, under the specials scheme (unlicensed medicines made for one patient's needs). It cannot be sold as a research product.
The legal category above is how The Longevity Archive reads Medicines and Healthcare products Regulatory Agency listings for BGE-102 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
BGE-102 in sport and the military
Whether BGE-102 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United Kingdom. Before you compete or get tested, look up BGE-102 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
BGE-102 in other countries
Frequently asked questions
Is BGE-102 legal in the United Kingdom?
No. BGE-102 is not approved for any medical use in the United Kingdom. Its legal category is "Investigational, not licensed". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.
Can I buy BGE-102 in the United Kingdom?
There is no approved product to buy. In the United Kingdom, BGE-102 has the legal category "Investigational, not licensed". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Is BGE-102 MHRA approved?
No. In the United Kingdom, BGE-102 has the legal category "Investigational, not licensed". That is not a MHRA approval to sell it. For comparison, its US FDA status is: Investigational; in early to mid-stage studies. On the evidence, 1 completed human trial is cited on its profile.
Related compounds in the United Kingdom
Full research profile
How BGE-102 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
BGE-102 profileThis page is general information about the legal status of BGE-102 in the United Kingdom, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Medicines and Healthcare products Regulatory Agency or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.